Hearing aids in Chalfont, Bucks
For the very latest Digital hearing aids and earwax removal techniques visit the Chalfont hearing Centre
The Chalfont hearing centre can proudly boast of being one of the best independent hearing clinics in Bucks. Leon Cox the lead audiologist and owner know a thing or two when it comes to hearing aids and clearing earwax.
Henley hearing clinic News:
Researchers Identify New Type of Vertigo, According to Study Published in ‘Neurology’
With vertigo, people have episodes of dizziness that can last from minutes to days. Vertigo can be caused by serious conditions, such as tumors, or conditions that are fairly benign, such the inner ear disorder Meniere’s disease. But for some people, no cause can be found.
In this new study, neurologists have identified a new type of vertigo where treatment may be effective.
“These conditions can be difficult to diagnose and quite debilitating for people, so it’s exciting to be able to discover this new diagnosis of a condition that may respond to treatment,” said study author Ji-Soo Kim, MD, PhD, of Seoul National University in Seongnam, South Korea.
To diagnose this new condition, the person sits in a dark room and the examiner moves the patient’s head forward and then the head is shaken horizontally for about 15 seconds. Then the patient opens his or her eyes and a video recording is taken of eye movements. The neurologists discovered that after the test, people with this new condition had eye movements called nystagmus that lasted longer than for other people. The new condition is called recurrent spontaneous vertigo with head-shaking nystagmus.
Among 338 people with vertigo with no known cause, 35 had this new condition and were included in the study. The participants had attacks of vertigo ranging from two or three times a week to once a year. They also experienced nausea or vomiting, headaches, and intolerance of head motions during the attacks.
The participants were compared to 35 people with other conditions that can cause vertigo, such Meniere’s disease, vestibular migraine, and vestibular neuritis. The test measured the time constant, or the time that represents the speed with which the reflexive eye movements can respond to change. For those with the new condition, the time constant during the primary phase of the nystagmus was 12 seconds, while it was six seconds for those with Meniere’s disease and five seconds for those with vestibular neuritis and vestibular migraine.
The neurologists also found that people with the new type of vertigo were more likely to have severe motion sickness than those with other types of vertigo.
A total of 20 of the 35 people with the new type of vertigo who had frequent attacks and severe symptoms were given preventive medication. About one-third of those had partial or complete recovery with the new medication. During the long-term follow-up of an average of 12 years after the first symptoms for 31 participants, five reported no more attacks, 14 said their symptoms had improved, and only one said symptoms had gotten worse.
Kim said that people with this condition may have a hyperactive mechanism in their vestibular system that helps the brain respond to movement of the body and in the environment.
“It’s possible that the vertigo occurs when this unstable mechanism is disrupted by factors either within the person’s body or in their environment,” Kim said.
The study was supported by the National Research Foundation of Korea. Learn more about the brain at www.BrainandLife.org, the American Academy of Neurology’s free patient and caregiver magazine and website focused on the intersection of neurologic disease and brain health. Follow Brain & Life on Facebook, Twitter, and Instagram.
The American Academy of Neurology is said to be the world’s largest association of neurologists and neuroscience professionals, with 34,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease, and epilepsy.
Original Paper: Lee S-U, Jeong-Yoon C, Hyo-Jung K, Ji-Soo, K. Recurrent spontaneous vertigo with interictal headshaking nystagmus. Neurology. 2018. Available at: http://n.neurology.org/content/early/2018/05/23/WNL.0000000000005689
Source: AAN, Neurology
Eargo Max is designed with an all-new chip set and operating system as well as “Flexi Domes,” that are designed to help decrease feedback and increase gain while preserving speech clarity, according to Eargo.
Each hearing aid also comes with sound profile memory and voice indicators that are designed to make Eargo Max even easier to use than its predecessor.
“We asked our customers, ‘How can we make Eargo even better?’ With their help we developed Eargo Max, the best invisible hearing aid on the planet,” said Christian Gormsen, Eargo’s CEO. “We’re proud of our latest creation but not spending any time patting ourselves on the back. There’s too much to do and we’re just getting started.”
Eargo provides support to clients transitioning to their hearing aids with the help of a team of licensed personal hearing guides. The company is backed by a group of investors (including NEA, The Nan Fung Group, Maveron, and Charles and Helen Schwab) who continue to invest their time, money, and resources into helping Eargo fulfill its mission.
Eargo Max Pricing & Availability
Eargo Max is available for purchase online at eargo.com or by phone at 1-800-61-EARGO. The Eargo hearing system is regularly priced at $2,500 but currently available for a limited time at the introductory price of $2,250. Financing is available for as low as $104 a month. Each purchase of an Eargo hearing aid comes with a 45-day money back guarantee, one-year warranty, and ongoing support by Eargo’s licensed hearing professionals. Eargo Max is only available in the United States.
People with single sided deafness (SSD) – those who are not able to hear in one ear – can face a number of challenges, such as missing out on speech coming from one direction, and a lack of stereo hearing that reduces the perceived quality of sound. The main issue, however, is that people with SSD have reduced speech intelligibility. This is due to several reasons: the inability to separate background noise from the signal of interest, the lack of binaural summation effect, and difficulties hearing the signal of interest coming from the side of the dead ear.
As with hearing impairment in general, SSD may lead to considerable lifestyle implications. Repeatedly missing out on conversation or finding communication especially challenging and energy consuming in particular situations, heightens the risk of withdrawal, which may affect work, family and social life.
Widex CROS has been developed to meet the needs of people with single sided deafness. Widex CROS picks up sound from the side with the deaf ear, and sends it wirelessly to a receiving hearing aid on the better ear. The Widex CROS is offered in the slim design Fashion model. This allows the user to adjust the volume and turn off transmission. Due to the WidexLink technology that’s used for transmitting sound to the receiving hearing aid, Widex CROS has a long battery life. The state-of -the-art speech understanding is delivered using the DREAM platform, which has already proved to be extremely successful with our patients. All Dream hearing aid models – in all price points can be used as receiving hearing aid.
I have been looking forward to this hearing aid for a while. I feel it will be useful to have an alternative to the proficient Audeo CROS from Phonak, which is currently the only practical option for patients with single sided deafness. I have had great results from treating unilateral hearing losses this year and if the performance matches the response that I have had from my current Widex Dream patients, it will definitely be a huge success. For me the improvement in battery life is a significant patient benefit.
As part of our continuing commitment to quality standards, we are currently looking for patients with single sided deafness who would be willing to trial the new hearing aid for us. We will be conducting clinical trials from January and require patients who have SSD to take part, it is not essential that you already wear a CROS/BiCROS system but it would be useful when making comparisons. If you have untreatable hearing loss in one ear (SSD) and you would like more information about Widex CROS or would like to take part in the study then please contact Leon Cox on 01494 765144.
We have finally got around to starting the hearing aid and tinnitus information blog. By connecting to our blog you can find information on hearing loss, hearing aids, technological advancements from Widex, Unitron, Phonak, Oticon, GN Resound, Starkey, Siemens and Bernafon hearing aids. Learn about changes in audiology and clinical practices. Find out about what Chalfont Hearing are doing in Buckinghamshire, London and Hertfordshire.